K200 실적 시즌 — 2026년 3분기 잠정실적KOSPI 200 earnings season — Q3 2026 preliminary resultsKOSPI200決算シーズン — 2026年第3四半期の速報値
분기보고서가 나오기 전, 회사들이 먼저 발표하는 잠정실적을 한 자리에 모았다. 누가 언제 발표했는지, 발표한 회사들의 영업이익과 순이익이 전년·전분기보다 얼마나 달라졌는지, 어느 업종이 늘고 줄었는지를 본다. 합계는 가장 큰 두 회사와 지주회사를 뺀 값도 같이 적는다. 밸류에이션은 P/B 를 기준으로 본다 — 역대 P/B 밴드 안에서 지금의 자리, 그리고 P/B 와 P/E 의 차이(이익이 평소보다 얼마나 많은가).This page gathers in one place the preliminary results that companies announce before their quarterly reports come out. It shows who announced and when, how much the operating profit and net profit of the companies that announced changed from a year earlier and from the previous quarter, and which sectors rose and fell. The sums are also given excluding the two largest companies and the holding companies. Valuation is viewed with P/B as the yardstick — where P/B now sits within its historical band, and the gap between P/B and P/E (how far earnings are above their usual level).四半期報告書が出る前に企業が先に発表する速報値(暫定決算)を一か所に集めた。誰がいつ発表したか、発表企業の営業利益と純利益が前年・前四半期からどれだけ変わったか、どの業種が増えて減ったかを見る。合計は最大2社と持株会社を除いた値も併記する。バリュエーションはPBRを基準に見る — 過去のPBRバンドの中での現在の位置、そしてPBRとPERの差(利益が平常よりどれだけ多いか)。
먼저 보는 세 줄 · 2026-11-11Three lines first · 2026-11-11まず見る三行 · 2026-11-11
K200 199종목 가운데 199곳이 2026년 3분기 실적을 발표했다(분기보고서 199곳). 발표한 회사의 영업이익 합계는 240.2조 — 전년비 +291.1%, 가장 큰 두 곳을 빼면 +30.5%, 지주회사까지 빼면 +19.4%. 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳.Of the 199 KOSPI 200 stocks, 199 have announced Q3 2026 results (199 quarterly reports). Operating profit of the companies that announced totals KRW 240.2trn — +291.1% YoY, +30.5% excluding the two largest and +19.4% also excluding holding companies. Operating profit rose at 102 companies and fell at 43.KOSPI200の199銘柄のうち199社が2026年第3四半期の実績を発表した(四半期報告書199社)。発表企業の営業利益合計は240.2兆ウォン — 前年同期比+291.1%、最大2社を除くと+30.5%、持株会社も除くと+19.4%。営業利益が増えた企業102社 · 減った企業43社。
밸류에이션의 기준은 P/B 다. 2013년부터 자료가 있는 같은 109사의 P/B 는 1.69배(역대 연말 0.80~1.48배) — 평소 대비 +42 가운데 P/E 쪽 -77 · ROE 쪽 +119. ROE 24.9% 는 평소의 3.3배다.P/B is the yardstick for valuation. P/B of the same 109 companies with data since 2013 is 1.69x (year-ends on record 0.80–1.48x) — of the +42 against its usual level, the P/E part is -77 and the ROE part +119. ROE of 24.9% is 3.3 times its usual level.バリュエーションの基準はPBRである。2013年からデータがある同じ109社のPBRは1.69倍(過去の年末0.80~1.48倍) — 平常値比+42のうちPER要因-77 · ROE要因+119。ROE 24.9%は平常値の3.3倍である。
K200 발표KOSPI 200 announcedKOSPI200 発表
199곳companies社
199종목 가운데 · 분기보고서 199곳out of 199 stocks · 199 quarterly reports199銘柄のうち · 四半期報告書199社
영업이익 증가 / 감소Operating profit up / down営業利益 増加 / 減少
102 / 43곳companies社
영업적자 9곳operating loss 9営業赤字9社
P/B (같은 109사)P/B (same 109 companies)PBR(同じ109社)
1.69배x倍
역대 연말 0.80~1.48 · 가운데 1.11year-ends on record 0.80–1.48 · median 1.11過去の年末0.80~1.48 · 中央値1.11
P/B 와 P/E 의 차이 = ROEGap between P/B and P/E = ROEPBRとPERの差 = ROE
24.9%
평소 7.6% · 잠정 반영 24.9%usual 7.6% · with preliminary results 24.9%平常値7.6% · 速報値反映24.9%
숫자는 각 회사의 영업(잠정)실적 공정공시에서 옮겼다. 공시에 적힌 전년동기·전분기 값이 그 회사의 정기보고서 값과 맞는 연결 기준 공시만 합계에 넣었다. 한 회사가 여러 번 공시했으면 그 분기 전체를 덮는 가장 최근 공시를 쓴다.Figures are taken from each company's fair-disclosure announcement of preliminary operating results. Only consolidated-basis announcements whose year-earlier and previous-quarter figures match the company's periodic-report values are included in the sums. Where a company announced several times, the most recent announcement covering the whole quarter is used.数値は各社の営業(暫定)実績の公正開示から転記した。開示に記載された前年同期・前四半期の値がその企業の定期報告書の値と一致する連結ベースの開示のみを合計に含めた。一社が複数回開示した場合は、その四半期全体をカバーする最新の開示を使う。
00
한 줄In one line一行で
K200 199종목 가운데 199곳이 2026년 3분기 실적을 발표했다(분기보고서 199곳). 발표한 회사의 영업이익 합계는 240.2조 — 전년비 +291.1%, 가장 큰 두 곳을 빼면 +30.5%, 지주회사까지 빼면 +19.4%. 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳. 밸류에이션의 기준은 P/B 다. 2013년부터 자료가 있는 같은 109사의 P/B 는 1.69배(역대 연말 0.80~1.48배) — 평소 대비 +42 가운데 P/E 쪽 -77 · ROE 쪽 +119. ROE 24.9% 는 평소의 3.3배다.
Of the 199 KOSPI 200 stocks, 199 have announced Q3 2026 results (199 quarterly reports). Operating profit of the companies that announced totals KRW 240.2trn — +291.1% YoY, +30.5% excluding the two largest and +19.4% also excluding holding companies. Operating profit rose at 102 companies and fell at 43. P/B is the yardstick for valuation. P/B of the same 109 companies with data since 2013 is 1.69x (year-ends on record 0.80–1.48x) — of the +42 against its usual level, the P/E part is -77 and the ROE part +119. ROE of 24.9% is 3.3 times its usual level.
⚠ 규율: 첫 발표 2026-10-01 · 공시 목록을 확인한 마지막 접수일 2026-11-11. 밸류에이션 화면의 숫자는 분기보고서가 나온 뒤에 바뀐다 — 이 페이지는 그 전의 발표값을 모은 것이다. 그 뒤에 들어온 분기보고서 197곳은 접수일을 따로 확인하지 않아 그림에는 발표 누적만 그렸다.
⚠ Discipline: First announcement 2026-10-01 · last filing date checked in the disclosure list 2026-11-11. The figures on the valuation pages change after the quarterly reports come out — this page collects the announced figures from before that. The 197 quarterly reports that arrived after that were not checked for their filing dates, so the chart shows only the cumulative announcements.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
02
발표한 회사 합계 — 영업이익과 순이익Totals for the companies that announced — operating profit and net profit発表企業の合計 — 営業利益と純利益
합계Totals合計Operating profit of KOSPI 200 companies that announced Q3 2026 results
발표한 회사 가운데 합계에 넣은 145사의 2026년 3분기 영업이익 합계 240.2조 — 전년 같은 분기 61.4조 대비 +291.1%, 전분기 대비 +16.1%. 영업이익이 가장 큰 두 곳을 빼면 49.4조 (전년비 +30.5% · 전분기비 -13.2%), 지주회사까지 빼면 39.3조 (전년비 +19.4%).
Of the companies that announced, the 145 included in the sums had total operating profit of KRW 240.2trn in Q3 2026 — +291.1% against KRW 61.4trn a year earlier and +16.1% against the previous quarter. Excluding the two companies with the largest operating profit: KRW 49.4trn (+30.5% YoY · -13.2% QoQ); also excluding holding companies: KRW 39.3trn (+19.4% YoY).
⚠ 규율: 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳 · 영업적자 9곳(적자 전환 3 · 흑자 전환 6). 합계에 넣은 회사 가운데 지주회사 9곳은 이 사이트의 정기보고서 자료가 별도 재무제표라 공시의 지난 분기 값과 대조하지 못했다(공시 값 그대로 · 지주회사를 뺀 합계에는 없다).
⚠ Discipline: Operating profit up at 102 companies · down at 43 · operating loss at 9 (3 turned to a loss · 6 turned to a profit). For 9 holding companies in the sums, this site's periodic-report data are separate financial statements, so their announcements could not be checked against past-quarter values (announced values as they are · not in the sums that exclude holding companies).
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
합계Totals合計Net income of KOSPI 200 companies that announced Q3 2026 results
순이익 합계 143.9조 — 전년비 +166.5% · 전분기비 -30.5%. 가장 큰 두 곳을 빼면 29.0조 (전년비 -0.7%), 지주회사까지 빼면 21.8조 (전년비 -17.5%).
Net profit in total KRW 143.9trn — +166.5% YoY · -30.5% QoQ. Excluding the two largest: KRW 29.0trn (-0.7% YoY); also excluding holding companies: KRW 21.8trn (-17.5% YoY).
⚠ 규율: 순이익을 적지 않은 공시는 순이익 합계에서 빠진다(영업이익 145사 · 순이익 143사). 매출 합계 924조 (전년비 +48.9%).
⚠ Discipline: Announcements that do not state net profit drop out of the net-profit sum (operating profit: 145 companies · net profit: 143). Revenue in total KRW 924trn (+48.9% YoY).
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
03
업종별 — 어디가 늘고 어디가 줄었나By sector — where profit rose and where it fell業種別 — どこが増え、どこが減ったか
업종Sectors業種Change in operating profit from a year earlier, by sector (largest sector shown separately)
업종
회사 수
영업이익
전년 같은 분기
전년비
전분기비
늘어난 곳
줄어든 곳
영업적자
IT·반도체
14
192.83조
25.45조
+657.6%
+26.9%
8
6
0
금융
16
11.22조
11.47조
-2.1%
-20.1%
9
7
0
소비재
34
10.46조
9.36조
+11.8%
-12.4%
26
8
0
지주
10
10.06조
4.92조
+104.3%
-13.5%
8
2
0
산업재
18
5.52조
4.07조
+35.6%
-8.7%
16
2
1
소재·화학·철강
18
2.13조
1.95조
+9.3%
-40.3%
11
7
2
에너지·유틸리티
6
2.08조
0.84조
+147.3%
+16.5%
3
3
1
헬스케어
10
1.40조
1.13조
+24.0%
+7.9%
7
2
1
통신
3
1.36조
0.75조
+81.1%
-13.1%
2
1
0
2차전지
7
1.10조
-0.03조
n/a
+299.8%
5
2
4
건설
4
1.01조
0.45조
+123.4%
+9.3%
3
1
0
방산
5
0.81조
1.09조
-26.2%
-54.3%
3
2
0
콘텐츠·엔터
1
0.19조
-0.04조
n/a
+10.3%
1
0
0
전년비 n/a = 전년 같은 분기 합계가 적자라 비율을 내지 않았다.
Sector
Companies
Operating profit
Same quarter a year earlier
YoY
QoQ
Up
Down
Operating loss
IT and semiconductors
14
KRW 192.83trn
KRW 25.45trn
+657.6%
+26.9%
8
6
0
Financials
16
KRW 11.22trn
KRW 11.47trn
-2.1%
-20.1%
9
7
0
Consumer
34
KRW 10.46trn
KRW 9.36trn
+11.8%
-12.4%
26
8
0
Holding companies
10
KRW 10.06trn
KRW 4.92trn
+104.3%
-13.5%
8
2
0
Industrials
18
KRW 5.52trn
KRW 4.07trn
+35.6%
-8.7%
16
2
1
Materials, chemicals and steel
18
KRW 2.13trn
KRW 1.95trn
+9.3%
-40.3%
11
7
2
Energy and utilities
6
KRW 2.08trn
KRW 0.84trn
+147.3%
+16.5%
3
3
1
Healthcare
10
KRW 1.40trn
KRW 1.13trn
+24.0%
+7.9%
7
2
1
Telecoms
3
KRW 1.36trn
KRW 0.75trn
+81.1%
-13.1%
2
1
0
Secondary batteries
7
KRW 1.10trn
KRW -0.03trn
n/a
+299.8%
5
2
4
Construction
4
KRW 1.01trn
KRW 0.45trn
+123.4%
+9.3%
3
1
0
Defence
5
KRW 0.81trn
KRW 1.09trn
-26.2%
-54.3%
3
2
0
Content and entertainment
1
KRW 0.19trn
KRW -0.04trn
n/a
+10.3%
1
0
0
YoY n/a = the sum for the same quarter a year earlier was a loss, so no ratio is given.
業種
企業数
営業利益
前年同期
前年同期比
前期比
増加
減少
営業赤字
IT・半導体
14
192.83兆ウォン
25.45兆ウォン
+657.6%
+26.9%
8
6
0
金融
16
11.22兆ウォン
11.47兆ウォン
-2.1%
-20.1%
9
7
0
消費財
34
10.46兆ウォン
9.36兆ウォン
+11.8%
-12.4%
26
8
0
持株会社
10
10.06兆ウォン
4.92兆ウォン
+104.3%
-13.5%
8
2
0
資本財
18
5.52兆ウォン
4.07兆ウォン
+35.6%
-8.7%
16
2
1
素材・化学・鉄鋼
18
2.13兆ウォン
1.95兆ウォン
+9.3%
-40.3%
11
7
2
エネルギー・公益
6
2.08兆ウォン
0.84兆ウォン
+147.3%
+16.5%
3
3
1
ヘルスケア
10
1.40兆ウォン
1.13兆ウォン
+24.0%
+7.9%
7
2
1
通信
3
1.36兆ウォン
0.75兆ウォン
+81.1%
-13.1%
2
1
0
二次電池
7
1.10兆ウォン
-0.03兆ウォン
n/a
+299.8%
5
2
4
建設
4
1.01兆ウォン
0.45兆ウォン
+123.4%
+9.3%
3
1
0
防衛
5
0.81兆ウォン
1.09兆ウォン
-26.2%
-54.3%
3
2
0
コンテンツ・エンタメ
1
0.19兆ウォン
-0.04兆ウォン
n/a
+10.3%
1
0
0
前年同期比n/a = 前年同期の合計が赤字のため比率を出していない。
IT·반도체 업종은 따로 적는다: 영업이익 25.5조 → 192.8조(+167.4조). 나머지 업종의 전년 대비 증감: 지주 +5.13조 · 산업재 +1.45조 · 에너지·유틸리티 +1.24조 · 2차전지 +1.13조 · 소비재 +1.11조 · 통신 +0.61조 · 건설 +0.56조 · 헬스케어 +0.27조 · 콘텐츠·엔터 +0.23조 · 소재·화학·철강 +0.18조 · 금융 -0.25조 · 방산 -0.29조.
The IT and semiconductors sector is shown separately: operating profit KRW 25.5trn → KRW 192.8trn (KRW +167.4trn). Change from a year earlier in the other sectors: Holding companies KRW +5.13trn · Industrials KRW +1.45trn · Energy and utilities KRW +1.24trn · Secondary batteries KRW +1.13trn · Consumer KRW +1.11trn · Telecoms KRW +0.61trn · Construction KRW +0.56trn · Healthcare KRW +0.27trn · Content and entertainment KRW +0.23trn · Materials, chemicals and steel KRW +0.18trn · Financials KRW -0.25trn · Defence KRW -0.29trn.
⚠ 규율: 업종 구분은 이 사이트의 밸류에이션 분류다. 지주는 자회사 연결 실적이 겹친다.
⚠ Discipline: The sector split is this site's valuation classification. Holding companies overlap with their subsidiaries' consolidated results.
⚠ 規律:業種区分はこのサイトのバリュエーション分類である。持株会社は子会社の連結実績と重複する。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
업종Sectors業種Companies with higher and lower operating profit than a year earlier, by sector
영업이익이 전년보다 늘어난 회사 비율이 높은 업종: 산업재 16/18 · 지주 8/10 · 헬스케어 7/9. 낮은 업종: 에너지·유틸리티 3/6 · 금융 9/16 · IT·반도체 8/14.
Sectors with the highest share of companies whose operating profit rose from a year earlier: Industrials 16/18 · Holding companies 8/10 · Healthcare 7/9. Lowest: Energy and utilities 3/6 · Financials 9/16 · IT and semiconductors 8/14.
⚠ 규율: 회사 수가 5곳 미만인 업종은 문장에서 뺐다(표에는 있다). 그림에는 회사 수가 많은 12개 업종만 그렸다 — 뺀 업종(콘텐츠·엔터)도 위 표에는 있다.
⚠ Discipline: Sectors with fewer than 5 companies are left out of the sentence (they are in the table). The chart shows only the 12 sectors with the most companies — the sectors left out (Content and entertainment) are also in the table above.
Limitations: 그림은 회사 수가 많은 12개 업종만 — 콘텐츠·엔터 제외 · 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: The chart shows only the 12 sectors with the most companies — Content and entertainment excluded · Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
04
밸류에이션 — 기준은 P/B, 그리고 P/B 와 P/E 의 차이Valuation — P/B as the yardstick, and the gap between P/B and P/Eバリュエーション — 基準はPBR、そしてPBRとPERの差
P/B 밴드P/B bandPBRバンドKOSPI 200 constituents: market value against book-value bands, year-ends since 2013
같은 109사의 P/B 는 2013년 말부터 2025년 말까지 연말 기준 0.80~1.48배(가운데 1.11배) 사이에 있었다. 지금(2026-11-12) 1.69배 — 13번의 연말 어느 때보다 높다. 2026년 9월 말 에는 2.23배였다.
Between end-2013 and end-2025, the P/B of the same 109 companies ranged 0.80–1.48x at year-ends (median 1.11x). Now (2026-11-12) 1.69x — higher than at any of the 13 year-ends. At end-September 2026 it was 2.23x.
⚠ 규율: 선은 그 시점의 자본에 역대 연말 P/B 의 최고·위 4분의 1·가운데·아래 4분의 1·최저를 곱한 값이다. 오른쪽 끝 두 점은 2026년 9월 말과 지금. 금융을 포함한 197사 전체의 지금 P/B 는 1.47배 · 금융 22사는 2021년부터만 자료가 있어 따로 — 연말 P/B 0.55 · 0.39 · 0.43 · 0.52 · 0.69 → 지금 0.62배.
⚠ Discipline: The lines are equity at each point multiplied by the highest, upper-quartile, median, lower-quartile and lowest year-end P/B on record. The two points at the right end are end-September 2026 and now. Including financials, P/B for all 197 companies is now 1.47x · the 22 financial companies have data only from 2021 onwards, so they are shown separately — year-end P/B 0.55 · 0.39 · 0.43 · 0.52 · 0.69 → now 0.62x.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
P/BP/BPBRP/B of the same companies at year-ends, at the latest quarter-end and now
⚠ 규율: 같은 기간 P/E 는 9.4~27.9배, ROE 는 3.8~11.4% 사이를 오갔다 — 셋 가운데 P/B 가 가장 덜 움직였다(최고 ÷ 최저: P/B 1.8배 · P/E 3.0배 · ROE 3.0배).
⚠ Discipline: Over the same period P/E ranged 9.4–27.9x and ROE 3.8–11.4% — of the three, P/B moved the least (highest ÷ lowest: P/B 1.8x · P/E 3.0x · ROE 3.0x).
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
P/B − P/EP/B − P/EPBR − PERP/B against its own average, split into a P/E part and an ROE part
P/B = P/E × ROE 이므로 P/B 와 P/E 의 차이는 ROE 다. 평소(2013~2025년 연말 평균)는 P/B 1.11배 · P/E 14.7배 · ROE 7.6%. 지금 P/B 가 평소보다 높은 정도 +42 = P/E 쪽 -77 + ROE 쪽 +119: ROE 24.9% 는 평소의 3.3배이고 P/E 6.8배는 평소보다 낮다. 2026년 9월 말: P/B +70 = P/E -49 + ROE +119(P/E 8.9배 · ROE 24.9%). 이번 분기 잠정실적을 얹으면 ROE 24.9% · P/E 6.8배 — P/B 는 그대로다.
Since P/B = P/E × ROE, the gap between P/B and P/E is ROE. The usual level (average of the 2013–2025 year-ends) is P/B 1.11x · P/E 14.7x · ROE 7.6%. P/B against its usual level now: +42 = P/E part -77 + ROE part +119: ROE of 24.9% is 3.3 times its usual level, and P/E of 6.8x is below its usual level. end-September 2026: P/B +70 = P/E -49 + ROE +119 (P/E 8.9x · ROE 24.9%). Adding this quarter's preliminary results gives ROE 24.9% · P/E 6.8x — P/B stays the same.
PBR = PER × ROEなので、PBRとPERの差はROEである。平常値(2013~2025年の年末平均)はPBR 1.11倍 · PER 14.7倍 · ROE 7.6%。現在のPBRの平常値比+42 = PER要因-77 + ROE要因+119:ROE 24.9%は平常値の3.3倍で、PER 6.8倍は平常値より低い。2026年9月末:PBR +70 = PER -49 + ROE +119(PER 8.9倍 · ROE 24.9%)。今四半期の速報値を加えるとROE 24.9% · PER 6.8倍 — PBRは変わらない。
⚠ 규율: 단위는 로그 차이 × 100(+69 가 2배). ROE = 직전 4개 분기 순이익 ÷ 자본. 잠정실적은 0곳(이 표본 시가총액의 0%)에 얹었고, 자본은 직전 분기 값 그대로다.
⚠ Discipline: Units are log difference × 100 (+69 = double). ROE = trailing four-quarter net profit ÷ equity. Preliminary results were added for 0 companies (0% of this sample's market capitalisation); equity is left at the previous quarter's value.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다. · 잠정실적은 회사 발표값(외부감사인 검토 전).
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013. · preliminary results are company-announced figures (before review by external auditors).
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
종목Stocks銘柄Where each company's P/B sits within its own history, by sector
역대 최고보다 높은 8곳 — 삼성전자, 삼성전기, LS ELECTRIC, 한미반도체, 한진칼, GS, 대우건설, 한올바이오파마
過去最低を下回る29社 — Samsung C&T、NAVER、Kakao、NC、LG H&H、Kangwon Land、Netmarble、CJ Cheiljedang、Kumho Petro Chemical、Lotte、Lotte Chemical、Cheil Worldwide、E-Mart、KEPCO Plant Service & Engineering、HL Mando、CJ Logistics、Otoki、Daewoong Pharma、Hite Jinro、Lotte Chilsung Beverage、Daewoong、Chong Kun Dang Pharmaceutical、LOTTE Fine Chemical、SK Chemicals、Miwon Specialty Chemical、Dongwon Systems、TKG Huchems、Korea Petro Chemical IND、Youngpoong
지수의 P/B 는 밴드 위쪽이지만 종목은 갈린다. 자기 역대 연말 범위와 견주면: 역대 최고보다 높은 곳 8곳 · 위 4분의 1 28곳 · 가운데 46곳 · 아래 4분의 1 37곳 · 역대 최저보다 낮은 곳 29곳.
The index P/B is in the upper part of its band, but individual stocks diverge. Against their own year-end ranges: above their highest 8 · upper quarter 28 · middle 46 · lower quarter 37 · below their lowest 29.
⚠ Discipline: Sectors with fewer than 3 companies are left out of the chart.
⚠ 規律:企業数が3社未満の業種は図から除いた。
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 그림은 회사 수가 3곳 이상인 업종만 · 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The chart shows only sectors with 3 or more companies · The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
종목Stocks銘柄P/B gap to own average by sector: how much is multiple, how much is earnings
⚠ 규율: 가운데 회사 값이라 두 몫의 합이 P/B 쪽 값과 꼭 맞지는 않는다. 이익이 난 해가 5개 미만인 회사는 빠진다.
⚠ Discipline: These are median-company values, so the two parts do not necessarily add up to the P/B value. Companies with fewer than 5 profitable years are left out.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表The largest companies: today's P/B within its own range, and the split
회사
P/B 지금
역대 연말 최저~최고(가운데)
위치
P/E 지금(평소)
ROE 지금(평소)
P/B 평소 대비
배수 쪽
이익 쪽
삼성전자
2.20
0.88~1.97 (1.43)
역대 최고 위
6.3 (11.8)
34.8% (11.7%)
+46
-63
+109
SK하이닉스
2.96
0.86~3.93 (1.65)
위 4분의 1
4.8 (9.7)
61.2% (15.9%)
+65
-69
+135
삼성전기
6.39
0.89~2.29 (1.45)
역대 최고 위
51.9 (25.0)
12.3% (5.7%)
+149
+73
+76
삼성바이오로직스
7.72
5.50~11.97 (6.54)
가운데
37.2 (95.7)
20.7% (8.1%)
-1
-94
+94
현대차
0.49
0.40~1.07 (0.55)
가운데
7.3 (6.1)
6.7% (9.5%)
-17
+18
-35
셀트리온
2.78
1.72~14.14 (6.02)
가운데
36.6 (65.6)
7.6% (7.7%)
-60
-58
-1
삼성E&A
0.57
0.77~1.63 (0.92)
역대 최저 아래
27.5 (25.1)
2.1% (3.9%)
-55
+9
-64
삼성SDI
1.54
0.68~3.27 (1.24)
가운데
39.7 (38.2)
3.9% (3.6%)
+12
+4
+8
기아
0.59
0.50~1.12 (0.78)
아래 4분의 1
5.3 (7.4)
11.1% (10.0%)
-24
-34
+10
SK
2.12
0.65~10.03 (1.35)
위 4분의 1
32.6 (18.4)
6.5% (9.2%)
+23
+57
-34
한화에어로스페이스
1.76
0.48~2.89 (0.86)
위 4분의 1
13.2 (16.5)
13.4% (5.9%)
+58
-23
+81
현대모비스
0.64
0.48~1.41 (0.73)
가운데
9.6 (9.0)
6.7% (8.2%)
-15
+6
-21
두산에너빌리티
2.63
0.19~4.02 (0.47)
위 4분의 1
85.4 (53.5)
3.1% (2.2%)
+82
+47
+35
NAVER
0.95
1.17~16.18 (4.73)
역대 최저 아래
17.7 (28.9)
5.4% (13.4%)
-141
-49
-92
LG전자
0.79
0.55~1.32 (0.74)
가운데
13.1 (20.2)
6.0% (3.9%)
-1
-43
+42
시가총액 기준일 2026-11-12.
Company
P/B now
Year-end low–high on record (median)
Position
P/E now (usual)
ROE now (usual)
P/B vs usual
Multiple part
Earnings part
Samsung Electronics
2.20
0.88~1.97 (1.43)
Above own record high
6.3 (11.8)
34.8% (11.7%)
+46
-63
+109
SK hynix
2.96
0.86~3.93 (1.65)
Upper quarter
4.8 (9.7)
61.2% (15.9%)
+65
-69
+135
Samsung Electro-Mechanics
6.39
0.89~2.29 (1.45)
Above own record high
51.9 (25.0)
12.3% (5.7%)
+149
+73
+76
Samsung Biologics
7.72
5.50~11.97 (6.54)
Middle
37.2 (95.7)
20.7% (8.1%)
-1
-94
+94
Hyundai Motor
0.49
0.40~1.07 (0.55)
Middle
7.3 (6.1)
6.7% (9.5%)
-17
+18
-35
Celltrion
2.78
1.72~14.14 (6.02)
Middle
36.6 (65.6)
7.6% (7.7%)
-60
-58
-1
Samsung C&T
0.57
0.77~1.63 (0.92)
Below own record low
27.5 (25.1)
2.1% (3.9%)
-55
+9
-64
Samsung SDI
1.54
0.68~3.27 (1.24)
Middle
39.7 (38.2)
3.9% (3.6%)
+12
+4
+8
Kia
0.59
0.50~1.12 (0.78)
Lower quarter
5.3 (7.4)
11.1% (10.0%)
-24
-34
+10
SK
2.12
0.65~10.03 (1.35)
Upper quarter
32.6 (18.4)
6.5% (9.2%)
+23
+57
-34
Hanwha Aerospace
1.76
0.48~2.89 (0.86)
Upper quarter
13.2 (16.5)
13.4% (5.9%)
+58
-23
+81
Hyundai Mobis
0.64
0.48~1.41 (0.73)
Middle
9.6 (9.0)
6.7% (8.2%)
-15
+6
-21
Doosan Enerbility
2.63
0.19~4.02 (0.47)
Upper quarter
85.4 (53.5)
3.1% (2.2%)
+82
+47
+35
NAVER
0.95
1.17~16.18 (4.73)
Below own record low
17.7 (28.9)
5.4% (13.4%)
-141
-49
-92
LG Electronics
0.79
0.55~1.32 (0.74)
Middle
13.1 (20.2)
6.0% (3.9%)
-1
-43
+42
Market capitalisation as of 2026-11-12.
企業
現在のPBR
過去の年末 最低~最高(中央値)
位置
現在のPER(平常値)
現在のROE(平常値)
PBRの平常値比
倍率要因
利益要因
Samsung Electronics
2.20
0.88~1.97 (1.43)
過去最高超
6.3 (11.8)
34.8% (11.7%)
+46
-63
+109
SK hynix
2.96
0.86~3.93 (1.65)
上位4分の1
4.8 (9.7)
61.2% (15.9%)
+65
-69
+135
Samsung Electro-Mechanics
6.39
0.89~2.29 (1.45)
過去最高超
51.9 (25.0)
12.3% (5.7%)
+149
+73
+76
Samsung Biologics
7.72
5.50~11.97 (6.54)
中央
37.2 (95.7)
20.7% (8.1%)
-1
-94
+94
Hyundai Motor
0.49
0.40~1.07 (0.55)
中央
7.3 (6.1)
6.7% (9.5%)
-17
+18
-35
Celltrion
2.78
1.72~14.14 (6.02)
中央
36.6 (65.6)
7.6% (7.7%)
-60
-58
-1
Samsung C&T
0.57
0.77~1.63 (0.92)
過去最低未満
27.5 (25.1)
2.1% (3.9%)
-55
+9
-64
Samsung SDI
1.54
0.68~3.27 (1.24)
中央
39.7 (38.2)
3.9% (3.6%)
+12
+4
+8
Kia
0.59
0.50~1.12 (0.78)
下位4分の1
5.3 (7.4)
11.1% (10.0%)
-24
-34
+10
SK
2.12
0.65~10.03 (1.35)
上位4分の1
32.6 (18.4)
6.5% (9.2%)
+23
+57
-34
Hanwha Aerospace
1.76
0.48~2.89 (0.86)
上位4分の1
13.2 (16.5)
13.4% (5.9%)
+58
-23
+81
Hyundai Mobis
0.64
0.48~1.41 (0.73)
中央
9.6 (9.0)
6.7% (8.2%)
-15
+6
-21
Doosan Enerbility
2.63
0.19~4.02 (0.47)
上位4分の1
85.4 (53.5)
3.1% (2.2%)
+82
+47
+35
NAVER
0.95
1.17~16.18 (4.73)
過去最低未満
17.7 (28.9)
5.4% (13.4%)
-141
-49
-92
LG Electronics
0.79
0.55~1.32 (0.74)
中央
13.1 (20.2)
6.0% (3.9%)
-1
-43
+42
時価総額の基準日:2026-11-12。
시가총액이 큰 15곳. P/B 평소 대비 = 배수(P/E) 쪽 + 이익(ROE) 쪽 — 로그 차이 × 100.
The 15 largest companies by market capitalisation. P/B against its usual level = multiple (P/E) part + earnings (ROE) part — log difference × 100.
⚠ Discipline: Cells that cannot be split because of a loss or too few profitable years are n/a.
⚠ 規律:赤字、または利益が出た年が少なく分けられない欄はn/a。
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
05
회사별By company企業別
표Table表Largest operating profits among companies that announced
회사
발표일
매출
영업이익
전년 같은 분기
전분기
순이익
삼성전자
10-29
195.25조
107.44조
12.17조
89.49조
75.14조
SK하이닉스
10-28
104.62조
83.33조
11.38조
60.54조
39.78조
SK이노베이션
10-29
28.77조
3.70조
5,856억
3.49조
2.64조
HD현대
10-28
22.08조
2.92조
1.70조
4.12조
1.38조
현대차
10-29
45.11조
2.68조
2.54조
2.85조
1.93조
KB금융
11-11
24.50조
2.37조
2.33조
2.71조
1.76조
신한지주
10-27
18.64조
1.91조
1.95조
2.48조
1.61조
기아
10-30
31.60조
1.82조
1.46조
2.63조
1.29조
하나금융지주
10-23
20.00조
1.63조
1.48조
1.59조
1.26조
HD한국조선해양
10-28
8.29조
1.45조
1.05조
1.65조
7,770억
우리금융지주
10-23
13.30조
1.42조
9,880억
1.32조
1.08조
S-Oil
11-02
11.97조
1.41조
2,292억
9,650억
1.44조
GS
11-05
7.27조
1.27조
8,706억
1.72조
6,804억
삼성물산
10-28
12.01조
1.14조
9,934억
1.03조
8,009억
iM금융지주
10-26
10.47조
1.03조
9,767억
9,151억
7,712억
연결 기준 · 발표값.
Company
Announced
Revenue
Operating profit
Same quarter a year earlier
Previous quarter
Net profit
Samsung Electronics
10-29
KRW 195.25trn
KRW 107.44trn
KRW 12.17trn
KRW 89.49trn
KRW 75.14trn
SK hynix
10-28
KRW 104.62trn
KRW 83.33trn
KRW 11.38trn
KRW 60.54trn
KRW 39.78trn
SK Innovation
10-29
KRW 28.77trn
KRW 3.70trn
5,856 KRW 100mn
KRW 3.49trn
KRW 2.64trn
HD Hyundai
10-28
KRW 22.08trn
KRW 2.92trn
KRW 1.70trn
KRW 4.12trn
KRW 1.38trn
Hyundai Motor
10-29
KRW 45.11trn
KRW 2.68trn
KRW 2.54trn
KRW 2.85trn
KRW 1.93trn
KB Financial Group
11-11
KRW 24.50trn
KRW 2.37trn
KRW 2.33trn
KRW 2.71trn
KRW 1.76trn
Shinhan Financial Group
10-27
KRW 18.64trn
KRW 1.91trn
KRW 1.95trn
KRW 2.48trn
KRW 1.61trn
Kia
10-30
KRW 31.60trn
KRW 1.82trn
KRW 1.46trn
KRW 2.63trn
KRW 1.29trn
Hana Financial Group
10-23
KRW 20.00trn
KRW 1.63trn
KRW 1.48trn
KRW 1.59trn
KRW 1.26trn
HD Korea Shipbuilding & Offshore Engineering
10-28
KRW 8.29trn
KRW 1.45trn
KRW 1.05trn
KRW 1.65trn
7,770 KRW 100mn
Woori Financial Group
10-23
KRW 13.30trn
KRW 1.42trn
9,880 KRW 100mn
KRW 1.32trn
KRW 1.08trn
S-Oil
11-02
KRW 11.97trn
KRW 1.41trn
2,292 KRW 100mn
9,650 KRW 100mn
KRW 1.44trn
GS
11-05
KRW 7.27trn
KRW 1.27trn
8,706 KRW 100mn
KRW 1.72trn
6,804 KRW 100mn
Samsung C&T
10-28
KRW 12.01trn
KRW 1.14trn
9,934 KRW 100mn
KRW 1.03trn
8,009 KRW 100mn
Industrial Bank OF Korea
10-26
KRW 10.47trn
KRW 1.03trn
9,767 KRW 100mn
9,151 KRW 100mn
7,712 KRW 100mn
Consolidated basis · announced figures.
企業
発表日
売上高
営業利益
前年同期
前四半期
純利益
Samsung Electronics
10-29
195.25兆ウォン
107.44兆ウォン
12.17兆ウォン
89.49兆ウォン
75.14兆ウォン
SK hynix
10-28
104.62兆ウォン
83.33兆ウォン
11.38兆ウォン
60.54兆ウォン
39.78兆ウォン
SK Innovation
10-29
28.77兆ウォン
3.70兆ウォン
5,856億ウォン
3.49兆ウォン
2.64兆ウォン
HD Hyundai
10-28
22.08兆ウォン
2.92兆ウォン
1.70兆ウォン
4.12兆ウォン
1.38兆ウォン
Hyundai Motor
10-29
45.11兆ウォン
2.68兆ウォン
2.54兆ウォン
2.85兆ウォン
1.93兆ウォン
KB Financial Group
11-11
24.50兆ウォン
2.37兆ウォン
2.33兆ウォン
2.71兆ウォン
1.76兆ウォン
Shinhan Financial Group
10-27
18.64兆ウォン
1.91兆ウォン
1.95兆ウォン
2.48兆ウォン
1.61兆ウォン
Kia
10-30
31.60兆ウォン
1.82兆ウォン
1.46兆ウォン
2.63兆ウォン
1.29兆ウォン
Hana Financial Group
10-23
20.00兆ウォン
1.63兆ウォン
1.48兆ウォン
1.59兆ウォン
1.26兆ウォン
HD Korea Shipbuilding & Offshore Engineering
10-28
8.29兆ウォン
1.45兆ウォン
1.05兆ウォン
1.65兆ウォン
7,770億ウォン
Woori Financial Group
10-23
13.30兆ウォン
1.42兆ウォン
9,880億ウォン
1.32兆ウォン
1.08兆ウォン
S-Oil
11-02
11.97兆ウォン
1.41兆ウォン
2,292億ウォン
9,650億ウォン
1.44兆ウォン
GS
11-05
7.27兆ウォン
1.27兆ウォン
8,706億ウォン
1.72兆ウォン
6,804億ウォン
Samsung C&T
10-28
12.01兆ウォン
1.14兆ウォン
9,934億ウォン
1.03兆ウォン
8,009億ウォン
Industrial Bank OF Korea
10-26
10.47兆ウォン
1.03兆ウォン
9,767億ウォン
9,151億ウォン
7,712億ウォン
連結ベース · 発表値。
영업이익이 큰 순서로 15곳.
The 15 companies with the largest operating profit.
営業利益が大きい順に15社。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表Largest increases in operating profit from a year earlier
회사
발표일
매출
영업이익
전년 같은 분기
전분기
순이익
삼성전자
10-29
195.25조
107.44조
12.17조
89.49조
75.14조
SK하이닉스
10-28
104.62조
83.33조
11.38조
60.54조
39.78조
SK이노베이션
10-29
28.77조
3.70조
5,856억
3.49조
2.64조
HD현대
10-28
22.08조
2.92조
1.70조
4.12조
1.38조
S-Oil
11-02
11.97조
1.41조
2,292억
9,650억
1.44조
삼성SDI
10-29
4.69조
4,078억
-5,913억
2,038억
3,422억
SK텔레콤
11-04
4.50조
5,523억
484억
5,660억
4,118억
우리금융지주
10-23
13.30조
1.42조
9,880억
1.32조
1.08조
삼성전기
10-28
3.76조
6,910억
2,603억
4,404억
4,850억
GS
11-05
7.27조
1.27조
8,706억
1.72조
6,804억
Company
Announced
Revenue
Operating profit
Same quarter a year earlier
Previous quarter
Net profit
Samsung Electronics
10-29
KRW 195.25trn
KRW 107.44trn
KRW 12.17trn
KRW 89.49trn
KRW 75.14trn
SK hynix
10-28
KRW 104.62trn
KRW 83.33trn
KRW 11.38trn
KRW 60.54trn
KRW 39.78trn
SK Innovation
10-29
KRW 28.77trn
KRW 3.70trn
5,856 KRW 100mn
KRW 3.49trn
KRW 2.64trn
HD Hyundai
10-28
KRW 22.08trn
KRW 2.92trn
KRW 1.70trn
KRW 4.12trn
KRW 1.38trn
S-Oil
11-02
KRW 11.97trn
KRW 1.41trn
2,292 KRW 100mn
9,650 KRW 100mn
KRW 1.44trn
Samsung SDI
10-29
KRW 4.69trn
4,078 KRW 100mn
-5,913 KRW 100mn
2,038 KRW 100mn
3,422 KRW 100mn
SK Telecom
11-04
KRW 4.50trn
5,523 KRW 100mn
484 KRW 100mn
5,660 KRW 100mn
4,118 KRW 100mn
Woori Financial Group
10-23
KRW 13.30trn
KRW 1.42trn
9,880 KRW 100mn
KRW 1.32trn
KRW 1.08trn
Samsung Electro-Mechanics
10-28
KRW 3.76trn
6,910 KRW 100mn
2,603 KRW 100mn
4,404 KRW 100mn
4,850 KRW 100mn
GS
11-05
KRW 7.27trn
KRW 1.27trn
8,706 KRW 100mn
KRW 1.72trn
6,804 KRW 100mn
企業
発表日
売上高
営業利益
前年同期
前四半期
純利益
Samsung Electronics
10-29
195.25兆ウォン
107.44兆ウォン
12.17兆ウォン
89.49兆ウォン
75.14兆ウォン
SK hynix
10-28
104.62兆ウォン
83.33兆ウォン
11.38兆ウォン
60.54兆ウォン
39.78兆ウォン
SK Innovation
10-29
28.77兆ウォン
3.70兆ウォン
5,856億ウォン
3.49兆ウォン
2.64兆ウォン
HD Hyundai
10-28
22.08兆ウォン
2.92兆ウォン
1.70兆ウォン
4.12兆ウォン
1.38兆ウォン
S-Oil
11-02
11.97兆ウォン
1.41兆ウォン
2,292億ウォン
9,650億ウォン
1.44兆ウォン
Samsung SDI
10-29
4.69兆ウォン
4,078億ウォン
-5,913億ウォン
2,038億ウォン
3,422億ウォン
SK Telecom
11-04
4.50兆ウォン
5,523億ウォン
484億ウォン
5,660億ウォン
4,118億ウォン
Woori Financial Group
10-23
13.30兆ウォン
1.42兆ウォン
9,880億ウォン
1.32兆ウォン
1.08兆ウォン
Samsung Electro-Mechanics
10-28
3.76兆ウォン
6,910億ウォン
2,603億ウォン
4,404億ウォン
4,850億ウォン
GS
11-05
7.27兆ウォン
1.27兆ウォン
8,706億ウォン
1.72兆ウォン
6,804億ウォン
전년 같은 분기보다 영업이익이 가장 많이 늘어난 10곳(금액 기준).
The 10 companies whose operating profit rose most from a year earlier (by amount).
前年同期より営業利益が最も増えた10社(金額ベース)。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表Largest decreases in operating profit from a year earlier
회사
발표일
매출
영업이익
전년 같은 분기
전분기
순이익
한국금융지주
11-05
11.18조
3,004억
8,491억
1.34조
2,818억
한화에어로스페이스
10-29
6.09조
4,520억
8,396억
1.37조
-367억
메리츠금융지주
11-11
13.13조
5,199억
8,623억
9,676억
4,905억
LG디스플레이
10-22
6.28조
2,506억
4,310억
-1,077억
7,556억
롯데케미칼
11-06
5.40조
-2,814억
-1,326억
1,101억
-2,898억
BNK금융지주
10-26
3.10조
2,395억
3,804억
2,357억
2,171억
고려아연
11-04
6.09조
1,417억
2,734억
5,871억
2,254억
크래프톤
11-10
9,714억
2,250억
3,486억
4,109억
-684억
LG화학
11-05
15.50조
5,612억
6,797억
5,996억
-6,000억
LG이노텍
10-27
6.37조
948억
2,037억
2,458억
952억
Company
Announced
Revenue
Operating profit
Same quarter a year earlier
Previous quarter
Net profit
Korea Investment Holdings
11-05
KRW 11.18trn
3,004 KRW 100mn
8,491 KRW 100mn
KRW 1.34trn
2,818 KRW 100mn
Hanwha Aerospace
10-29
KRW 6.09trn
4,520 KRW 100mn
8,396 KRW 100mn
KRW 1.37trn
-367 KRW 100mn
Meritz Financial Group
11-11
KRW 13.13trn
5,199 KRW 100mn
8,623 KRW 100mn
9,676 KRW 100mn
4,905 KRW 100mn
LG Display
10-22
KRW 6.28trn
2,506 KRW 100mn
4,310 KRW 100mn
-1,077 KRW 100mn
7,556 KRW 100mn
Lotte Chemical
11-06
KRW 5.40trn
-2,814 KRW 100mn
-1,326 KRW 100mn
1,101 KRW 100mn
-2,898 KRW 100mn
BNK Financial Group
10-26
KRW 3.10trn
2,395 KRW 100mn
3,804 KRW 100mn
2,357 KRW 100mn
2,171 KRW 100mn
Korea Zinc
11-04
KRW 6.09trn
1,417 KRW 100mn
2,734 KRW 100mn
5,871 KRW 100mn
2,254 KRW 100mn
Krafton
11-10
9,714 KRW 100mn
2,250 KRW 100mn
3,486 KRW 100mn
4,109 KRW 100mn
-684 KRW 100mn
LG Chem
11-05
KRW 15.50trn
5,612 KRW 100mn
6,797 KRW 100mn
5,996 KRW 100mn
-6,000 KRW 100mn
LG Innotek
10-27
KRW 6.37trn
948 KRW 100mn
2,037 KRW 100mn
2,458 KRW 100mn
952 KRW 100mn
企業
発表日
売上高
営業利益
前年同期
前四半期
純利益
Korea Investment Holdings
11-05
11.18兆ウォン
3,004億ウォン
8,491億ウォン
1.34兆ウォン
2,818億ウォン
Hanwha Aerospace
10-29
6.09兆ウォン
4,520億ウォン
8,396億ウォン
1.37兆ウォン
-367億ウォン
Meritz Financial Group
11-11
13.13兆ウォン
5,199億ウォン
8,623億ウォン
9,676億ウォン
4,905億ウォン
LG Display
10-22
6.28兆ウォン
2,506億ウォン
4,310億ウォン
-1,077億ウォン
7,556億ウォン
Lotte Chemical
11-06
5.40兆ウォン
-2,814億ウォン
-1,326億ウォン
1,101億ウォン
-2,898億ウォン
BNK Financial Group
10-26
3.10兆ウォン
2,395億ウォン
3,804億ウォン
2,357億ウォン
2,171億ウォン
Korea Zinc
11-04
6.09兆ウォン
1,417億ウォン
2,734億ウォン
5,871億ウォン
2,254億ウォン
Krafton
11-10
9,714億ウォン
2,250億ウォン
3,486億ウォン
4,109億ウォン
-684億ウォン
LG Chem
11-05
15.50兆ウォン
5,612億ウォン
6,797億ウォン
5,996億ウォン
-6,000億ウォン
LG Innotek
10-27
6.37兆ウォン
948億ウォン
2,037億ウォン
2,458億ウォン
952億ウォン
전년 같은 분기보다 영업이익이 가장 많이 줄어든 10곳(금액 기준).
The 10 companies whose operating profit fell most from a year earlier (by amount).
前年同期より営業利益が最も減った10社(金額ベース)。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表Companies whose operating profit changed sign from a year earlier
구분
회사
전년 같은 분기
이번 분기
흑자 전환
삼성SDI
-5,913억
4,078억
흑자 전환
하이브
-422억
1,885억
흑자 전환
엔씨소프트
-75억
1,196억
흑자 전환
한화솔루션
-74억
905억
흑자 전환
OCI홀딩스
-533억
680억
흑자 전환
OCI
-103억
303억
적자 전환
엘앤에프
221억
-265억
적자 전환
금호석유
844억
-208억
적자 전환
지역난방공사
894억
-79억
적자 지속
롯데케미칼
-1,326억
-2,814억
적자 지속
SKC
-549억
-496억
적자 지속
SK아이이테크놀로지
-472억
-368억
적자 지속
에코프로머티
-251억
-290억
적자 지속
두산로보틱스
-153억
-134억
적자 지속
SK바이오사이언스
-194억
-112억
영업이익 기준.
Type
Company
Same quarter a year earlier
This quarter
Turned to profit
Samsung SDI
-5,913 KRW 100mn
4,078 KRW 100mn
Turned to profit
Hybe
-422 KRW 100mn
1,885 KRW 100mn
Turned to profit
NC
-75 KRW 100mn
1,196 KRW 100mn
Turned to profit
Hanwha Solutions
-74 KRW 100mn
905 KRW 100mn
Turned to profit
OCI Holdings
-533 KRW 100mn
680 KRW 100mn
Turned to profit
OCI
-103 KRW 100mn
303 KRW 100mn
Turned to loss
L&F
221 KRW 100mn
-265 KRW 100mn
Turned to loss
Kumho Petro Chemical
844 KRW 100mn
-208 KRW 100mn
Turned to loss
Korea District Heating
894 KRW 100mn
-79 KRW 100mn
Still loss-making
Lotte Chemical
-1,326 KRW 100mn
-2,814 KRW 100mn
Still loss-making
SKC
-549 KRW 100mn
-496 KRW 100mn
Still loss-making
SK ie technology
-472 KRW 100mn
-368 KRW 100mn
Still loss-making
Ecopro Materials
-251 KRW 100mn
-290 KRW 100mn
Still loss-making
Doosan Robotics
-153 KRW 100mn
-134 KRW 100mn
Still loss-making
SK Bioscience
-194 KRW 100mn
-112 KRW 100mn
Operating profit basis.
区分
企業
前年同期
今四半期
黒字転換
Samsung SDI
-5,913億ウォン
4,078億ウォン
黒字転換
Hybe
-422億ウォン
1,885億ウォン
黒字転換
NC
-75億ウォン
1,196億ウォン
黒字転換
Hanwha Solutions
-74億ウォン
905億ウォン
黒字転換
OCI Holdings
-533億ウォン
680億ウォン
黒字転換
OCI
-103億ウォン
303億ウォン
赤字転落
L&F
221億ウォン
-265億ウォン
赤字転落
Kumho Petro Chemical
844億ウォン
-208億ウォン
赤字転落
Korea District Heating
894億ウォン
-79億ウォン
赤字継続
Lotte Chemical
-1,326億ウォン
-2,814億ウォン
赤字継続
SKC
-549億ウォン
-496億ウォン
赤字継続
SK ie technology
-472億ウォン
-368億ウォン
赤字継続
Ecopro Materials
-251億ウォン
-290億ウォン
赤字継続
Doosan Robotics
-153億ウォン
-134億ウォン
赤字継続
SK Bioscience
-194億ウォン
-112億ウォン
営業利益ベース。
흑자 전환 6곳 · 적자 전환 3곳 · 적자 지속 6곳.
Turned to a profit: 6 · turned to a loss: 3 · still loss-making: 6.
黒字転換6社 · 赤字転落3社 · 赤字継続6社。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表Companies that announced but are left out of the sums
회사
발표일
이유
대웅제약
11-04
별도 기준 공시(또는 공시 통화가 다름)
대한항공
10-15
별도 기준 공시(또는 공시 통화가 다름)
두산밥캣
10-29
별도 기준 공시(또는 공시 통화가 다름)
오리온
11-11
월별 실적만 공시
유한양행
10-28
별도 기준 공시(또는 공시 통화가 다름)
한국가스공사
11-11
월별 실적만 공시
별도 기준 공시는 연결 기준 합계와 섞지 않는다.
Company
Announced
Reason
Daewoong Pharma
11-04
Separate (parent-only) basis, or a different reporting currency
Korean Air Lines
10-15
Separate (parent-only) basis, or a different reporting currency
Doosan Bobcat
10-29
Separate (parent-only) basis, or a different reporting currency
Orion
11-11
Monthly results only
Yuhan
10-28
Separate (parent-only) basis, or a different reporting currency
KoreaGasCorporation
11-11
Monthly results only
Separate-basis announcements are not mixed into the consolidated sums.
企業
発表日
理由
Daewoong Pharma
11-04
個別ベースの開示(または開示通貨が異なる)
Korean Air Lines
10-15
個別ベースの開示(または開示通貨が異なる)
Doosan Bobcat
10-29
個別ベースの開示(または開示通貨が異なる)
Orion
11-11
月次実績のみ開示
Yuhan
10-28
個別ベースの開示(または開示通貨が異なる)
KoreaGasCorporation
11-11
月次実績のみ開示
個別ベースの開示は連結ベースの合計と混ぜない。
발표는 했지만 합계에서 뺀 6곳과 그 이유.
The 6 companies that announced but are left out of the sums, and why.
発表はしたが合計から除いた6社とその理由。
Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
표Table表Preliminary versus filed figures for companies whose quarterly report has arrived
회사
영업이익(발표)
영업이익(보고서)
차이
순이익(발표)
순이익(보고서)
HD현대
2.92조
2,120억
-27,077억
1.38조
1,989억
SK이노베이션
3.70조
1.75조
-19,541억
2.64조
1.85조
GS
1.27조
305억
-12,443억
6,804억
216억
삼성물산
1.14조
2,837억
-8,591억
8,009억
4,911억
두산
4,594억
1,683억
-2,911억
1,031억
510억
DL
1,740억
5억
-1,735억
1,650억
-88억
카카오
2,403억
1,178억
-1,225억
1,777억
1,004억
한국앤컴퍼니
665억
321억
-344억
465억
153억
동원시스템즈
240억
154억
-86억
53억
-34억
POSCO홀딩스
9,400억
9,447억
+47억
3,800억
3,798억
신한지주
1.91조
1.91조
+28억
1.61조
1.61조
세아제강지주
933억
905억
-28억
68억
45억
종근당
237억
220억
-16억
188억
193억
삼성중공업
3,384억
3,383억
-1억
4,708억
4,708억
넷마블
504억
503억
-1억
222억
222억
보고서 값 = 분기보고서 연결 재무제표의 3개월 값.
Company
Operating profit (announced)
Operating profit (report)
Difference
Net profit (announced)
Net profit (report)
HD Hyundai
KRW 2.92trn
2,120 KRW 100mn
-27,077 KRW 100mn
KRW 1.38trn
1,989 KRW 100mn
SK Innovation
KRW 3.70trn
KRW 1.75trn
-19,541 KRW 100mn
KRW 2.64trn
KRW 1.85trn
GS
KRW 1.27trn
305 KRW 100mn
-12,443 KRW 100mn
6,804 KRW 100mn
216 KRW 100mn
Samsung C&T
KRW 1.14trn
2,837 KRW 100mn
-8,591 KRW 100mn
8,009 KRW 100mn
4,911 KRW 100mn
Doosan
4,594 KRW 100mn
1,683 KRW 100mn
-2,911 KRW 100mn
1,031 KRW 100mn
510 KRW 100mn
DL
1,740 KRW 100mn
5 KRW 100mn
-1,735 KRW 100mn
1,650 KRW 100mn
-88 KRW 100mn
Kakao
2,403 KRW 100mn
1,178 KRW 100mn
-1,225 KRW 100mn
1,777 KRW 100mn
1,004 KRW 100mn
Hankook & Company
665 KRW 100mn
321 KRW 100mn
-344 KRW 100mn
465 KRW 100mn
153 KRW 100mn
Dongwon Systems
240 KRW 100mn
154 KRW 100mn
-86 KRW 100mn
53 KRW 100mn
-34 KRW 100mn
POSCO Holdings
9,400 KRW 100mn
9,447 KRW 100mn
+47 KRW 100mn
3,800 KRW 100mn
3,798 KRW 100mn
Shinhan Financial Group
KRW 1.91trn
KRW 1.91trn
+28 KRW 100mn
KRW 1.61trn
KRW 1.61trn
SeAH Steel Holdings
933 KRW 100mn
905 KRW 100mn
-28 KRW 100mn
68 KRW 100mn
45 KRW 100mn
Chong Kun Dang Pharmaceutical
237 KRW 100mn
220 KRW 100mn
-16 KRW 100mn
188 KRW 100mn
193 KRW 100mn
Samsung Heavy Industries
3,384 KRW 100mn
3,383 KRW 100mn
-1 KRW 100mn
4,708 KRW 100mn
4,708 KRW 100mn
Netmarble
504 KRW 100mn
503 KRW 100mn
-1 KRW 100mn
222 KRW 100mn
222 KRW 100mn
Report value = the three-month figure in the consolidated financial statements of the quarterly report.
企業
営業利益(発表)
営業利益(報告書)
差
純利益(発表)
純利益(報告書)
HD Hyundai
2.92兆ウォン
2,120億ウォン
-27,077億ウォン
1.38兆ウォン
1,989億ウォン
SK Innovation
3.70兆ウォン
1.75兆ウォン
-19,541億ウォン
2.64兆ウォン
1.85兆ウォン
GS
1.27兆ウォン
305億ウォン
-12,443億ウォン
6,804億ウォン
216億ウォン
Samsung C&T
1.14兆ウォン
2,837億ウォン
-8,591億ウォン
8,009億ウォン
4,911億ウォン
Doosan
4,594億ウォン
1,683億ウォン
-2,911億ウォン
1,031億ウォン
510億ウォン
DL
1,740億ウォン
5億ウォン
-1,735億ウォン
1,650億ウォン
-88億ウォン
Kakao
2,403億ウォン
1,178億ウォン
-1,225億ウォン
1,777億ウォン
1,004億ウォン
Hankook & Company
665億ウォン
321億ウォン
-344億ウォン
465億ウォン
153億ウォン
Dongwon Systems
240億ウォン
154億ウォン
-86億ウォン
53億ウォン
-34億ウォン
POSCO Holdings
9,400億ウォン
9,447億ウォン
+47億ウォン
3,800億ウォン
3,798億ウォン
Shinhan Financial Group
1.91兆ウォン
1.91兆ウォン
+28億ウォン
1.61兆ウォン
1.61兆ウォン
SeAH Steel Holdings
933億ウォン
905億ウォン
-28億ウォン
68億ウォン
45億ウォン
Chong Kun Dang Pharmaceutical
237億ウォン
220億ウォン
-16億ウォン
188億ウォン
193億ウォン
Samsung Heavy Industries
3,384億ウォン
3,383億ウォン
-1億ウォン
4,708億ウォン
4,708億ウォン
Netmarble
504億ウォン
503億ウォン
-1億ウォン
222億ウォン
222億ウォン
報告書の値 = 四半期報告書の連結財務諸表の3か月の値。
분기보고서가 들어온 150곳의 발표값과 보고서 값 — 차이가 큰 순서로 15곳. 영업이익이 1억 넘게 달라진 곳 13곳.
Announced and filed figures for the 150 companies whose quarterly report has arrived — the 15 with the largest differences. Companies whose operating profit differs by more than KRW 100mn: 13.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
∞
천장 — 이 페이지가 말할 수 없는 것Ceilings — what this page cannot say限界 — このページが言えないこと
발표값이다. 외부감사인 검토 전이고, 분기보고서에서 달라질 수 있다.
발표한 회사만의 합계다. 아직 발표하지 않은 회사가 들어오면 합계와 증감률이 달라진다.
지주회사는 겹친다. 연결 실적에 상장 자회사의 이익이 들어 있어 합계가 부풀려진다 — 지주회사를 뺀 값을 같이 본다.
별도 기준 · 달러 공시 · 월별 공시 회사는 합계에 없다.
P/B 밴드는 같은 회사들만의 것이다. 2013년부터 자료가 있는 회사만 더했고 금융회사는 없다. 연말 값이라 연중 고점과 저점은 잡히지 않는다.
P/B 와 P/E 의 차이는 ROE 다. 이익이 평소보다 많을 때 P/E 는 낮아 보인다 — 그래서 기준을 P/B 에 둔다.
These are announced figures. They are before review by external auditors and may change in the quarterly reports.
The sums cover only the companies that have announced. The sums and growth rates change as the companies yet to announce come in.
Holding companies overlap. Their consolidated results include the profits of listed subsidiaries, which inflates the sums — the values excluding holding companies are shown alongside.
Companies announcing on a separate basis, in dollars or monthly are not in the sums.
The P/B band covers the same companies only. Only companies with data since 2013 are added, and there are no financial companies. These are year-end values, so intra-year highs and lows are not captured.
The gap between P/B and P/E is ROE. When earnings are above their usual level, P/E looks low — which is why P/B is used as the yardstick.